LGNDLigand Pharmaceuticals Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 18029
Ticker: LGND
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1994-11-25
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: LGND

Detail

Enriched 2026-08-14 20:47

Market cap: $5,846,516,051.43
Shares outstanding (class): 20,041,061
Shares outstanding (weighted): 19,935,609
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 47
Location: SAN DIEGO, CA
Homepage: https://www.ligand.com
Description: Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Market cap and share counts drift.

Funds holding this security

184 funds · 186 positions · $1.48B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Small-Cap ETF iShares Trust	IJR	$235.97M	0.26%	1,181,928 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$118.72M	0.01%	594,655 NS	FIGI
Franklin Dynatech Fund Franklin Custodian Funds	—	$104.82M	0.42%	525,000 NS	FIGI
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$97.07M	1.87%	486,184 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$94.66M	0.13%	474,108 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$86.06M	0.05%	431,066 NS	FIGI
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$54.81M	0.09%	274,538 NS	FIGI
Janus Henderson Venture Fund JANUS INVESTMENT FUND	—	$53.12M	1.73%	266,062 NS	FIGI
DWS Small Cap Core Fund DEUTSCHE DWS INVESTMENT TRUST	—	$51.91M	4.95%	260,000 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$43.83M	0.05%	219,510 NS	FIGI
Victory Sycamore Small Company Opportunity Fund Victory Portfolios	—	$39.93M	0.90%	200,000 NS	FIGI
Loomis Sayles Small Cap Growth Fund LOOMIS SAYLES FUNDS II	—	$39.44M	2.05%	197,535 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 600(TM) S… SPDR SERIES TRUST	SPSM	$35.57M	0.26%	178,176 NS	FIGI
iShares S&P Small-Cap 600 Growth ETF iShares Trust	IJT	$33.90M	0.52%	169,811 NS	FIGI
Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I	—	$30.44M	4.11%	152,444 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERLGND
FIGI_COMPOSITEBBG000BKF014
FIGI_SHARE_CLASSBBG001S8CH99
CIK0000886163
ISINUS53220K5048
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Ligand Pharmaceuticals is a biopharmaceutical company focused on drug development and licensing, fitting the pharmaceuticals industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.